IP Library Granted Patent US 8,535,644
Granted Patent B2
US 8,535,644 · App. 12/578,303 · Granted Sep 17, 2013

Tunable hydrogel microparticles

Inventors: Ramin Haghgooie (Arlington, MA); Patrick Seamus Doyle (Cambridge, MA); Mehmet Toner (Wellesley, MA); Daniel Colin Pregibon (Cambridge, MA)
Assignees: Massachusetts Institute of Technology; The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,535,644
App. No.
12/578,303
Granted
Sep 17, 2013
Kind
B2
Abstract

Techniques are provided to produce and use non-spherical colloidal particles with independently tuned size, shape, flexibility, and chemical properties. A pre-polymer mixture for forming hydrogel particles includes a percentage of PEGDA selected to impart a target stiffness to the particles and includes, a percentage of acrylic acid selected to impart an independent target chemical function to the particles. The mixture also includes a percentage of photo-initiator to polymerize PEGDA upon exposure to a light source to impart an independently selected target size or shape or both to the particles.

Claims (26)

1. A particle of ring shape comprising:

PEGDA of molecular weight about 700 daltons in an amount of at least 10 percent by volume;

an active substance; and

PEG of molecular weight about 200 daltons,

wherein a total amount of PEG, PEGDA and active substance is from about 30 to about 95 percent by volume of the particle.

2. A particle as recited in claim 1 , wherein the amount of PEGDA is selected to impart to the particle a stiffness in a range corresponding to a range of pressures to move an 8 micron particle through a constriction 4 microns across, wherein the range of pressures is between about 0.05 millimeters of mercury (mmHg) and about 100 mmHg.

3. A particle as recited in claim 1 , wherein the active substance comprises a member of the group comprising drugs, detection labels including fluorophores, acrylic acid and other acrylate chemistries.

4. A particle as recited in claim 1 , wherein the active substance comprises a biodegradable cross-linker molecule.

5. A particle as recited in claim 1 , wherein the particle is bound to a target affinity molecule.

6. A ring shaped hydrogel particle having a diameter of about 3 microns and stiffness of a red blood cell comprising:

PEGDA of molecular weight about 700 daltons in an amount of at least 10 percent by volume;

an active substance; and

PEG of molecular weight about 200 daltons.

7. A ring shaped hydrogel particle as recited in claim 6 , wherein:

a total amount of PEG, PEGDA and active substance is about 65 percent by volume of the particle.

8. A composition comprising a plurality of ring shaped particles, each particle comprising:

PEGDA of molecular weight about 700 daltons in an amount of at least 10 percent by volume;

an active substance; and

PEG of molecular weight about 200 daltons,

wherein a total amount of PEG, PEGDA and active substance is from about 30 to about 95 percent by volume of the particle.

9. A composition as recited in claim 8 , wherein the composition is formulated for administration to an animal.

10. A composition as recited in claim 8 , wherein the animal is a mammal and the particle is administered intravenously, intraarterially, intraperitoneally or in cerebrospinal fluid of the animal.

11. A composition as recited in claim 8 , wherein the composition is formulated for topical administration to an animal.

12. A composition as recited in claim 8 , wherein the composition is formulated as a paint additive.

13. A composition as recited in claim 8 wherein the composition is formulated for animal consumption.

14. A composition as recited in claim 9 , wherein the particle is a ring shaped hydrogel particle having a diameter of about 8 microns and a stiffness of red blood cells.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jan 14, 2010
From: THE GENERAL HOSPITAL CORPORATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023782/0528 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2009
From: DOYLE, PATRICK SEAMUS; PREGIBON, DANIEL COLIN
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 023365/0272 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2009
From: HAGHGOOIE, RAMIN
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 023365/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2009
From: HAGHGOOIE, RAMIN; TONER, MEHMET
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 023365/0461 →
Continuity (2)
Provisional Application 61195844 · Oct 10, 2008
Related Publication 20100092393A1 · Apr 15, 2010